The release of two key draft FDA Guidances on abuse liability assessments on drugs* and abuse-deterrent products has resulted in increased demand for human abuse liability studies. In response, Cambridge Cognition, the global leader in touchscreen cognitive assessments for clinical trials, has formed a scientific partnership with Altreos Research Partners, Inc., a leading provider of scientific, regulatory and operational input on abuse liability assessments.
20 August, 2014
Converting stem cell data into sounds could enable GPs to make instant, non-invasive cancer diagnoses during a routine check-up.With waiting times for cancer tests at a six-year high, this could significantly reduce the agonising and potentially life-threatening wait for patients and improve Government waiting time targets.*
18 August, 2014
It has been more than 20 years since scientists discovered that mutations in the gene huntingtin cause the devastating progressive neurological condition Huntington’s disease, which involves involuntary movements, emotional disturbance and cognitive impairment. Surprisingly little, however, has been known about the gene’s role in normal brain activity.
13 August, 2014